Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014

Publisher Name:
Published Date: 15-Apr-2014
No. of pages: 164

GlobalData’s clinical trial report, “Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014″ provides data on the Metastatic Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Prostate Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents For This Report

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 9

Metastatic Prostate Cancer 9

Report Guidance 9

Clinical Trials by Region 10

Clinical Trials and Average Enrollment by Country 11

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13

Top Five Countries Contributing to Clinical Trials in Europe 14

Top Countries Contributing to Clinical Trials in North America 15

Top Countries Contributing to Clinical Trials in Middle East and Africa 16

Top Five Countries Contributing to Clinical Trials in Central and South America 17

Clinical Trials by G7 Countries: Proportion of Metastatic Prostate Cancer to Oncology Clinical Trials 18

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Metastatic Prostate Cancer to Oncology Clinical Trials 21

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 27

Unaccomplished Trials of Metastatic Prostate Cancer 28

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Metastatic Prostate Cancer Therapeutics Clinical Trials 34

Prominent Drugs 36

Latest Clinical Trials News on Metastatic Prostate Cancer 37

Apr 02, 2014: Bayer Initiates Phase 3 Trial of Xofigo (radium Ra 223 dichloride) Injection in Combination with Abiraterone Acetate for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Bone Predominant Metastatic Castration-Resistant Prostate Cancer 37

Jan 30, 2014: Progenics Pharmaceuticals Presents Positive Data From a Phase 2 Trial of PSMA ADC in Patients With Chemotherapy Experienced Metastatic Castrate Resistant Prostate Cancer 37

Jan 28, 2014: Medivation and Astellas Announce Final Results From the Phase 3 PREVAIL Trial of Enzalutamide in Men With Metastatic Prostate Cancer Progressing on Androgen Deprivation Therapy 38

Jun 02, 2012: Zytiga’s Phase III Results Show Significant Improvement In Radiographic Progression-Free Survival And Trend For Increased Overall Survival In Metastatic Prostate Cancer Patients 40

Feb 24, 2012: Active Biotech And Ipsen Report Tasquinimod Phase II Long Term Safety Data At 27th European Association Of Urology Congress 41

Clinical Trial Profiles 42

Clinical Trial Overview of Top Companies 42

Johnson & Johnson 42

Clinical Trial Overview of Johnson & Johnson 42

Astellas Pharma Inc. 44

Clinical Trial Overview of Astellas Pharma Inc. 44

AstraZeneca PLC 45

Clinical Trial Overview of AstraZeneca PLC 45

Medivation, Inc. 46

Clinical Trial Overview of Medivation, Inc. 46

Sanofi 47

Clinical Trial Overview of Sanofi 47

Ipsen S.A. 48

Clinical Trial Overview of Ipsen S.A. 48

Bristol-Myers Squibb Company 49

Clinical Trial Overview of Bristol-Myers Squibb Company 49

Pfizer Inc. 50

Clinical Trial Overview of Pfizer Inc. 50

Novartis AG 51

Clinical Trial Overview of Novartis AG 51

Eli Lilly and Company 52

Clinical Trial Overview of Eli Lilly and Company 52

Clinical Trial Overview of Top Institutes / Government 53

National Cancer Institute 53

Clinical Trial Overview of National Cancer Institute 53

European Organization for Research and Treatment of Cancer 56

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 56

Memorial Sloan Kettering Cancer Center 57

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 57

Barbara Ann Karmanos Cancer Institute 58

Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 58

The University of Texas M. D. Anderson Cancer Center 59

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59

Southwest Oncology Group 60

Clinical Trial Overview of Southwest Oncology Group 60

OHSU Knight Cancer Institute 61

Clinical Trial Overview of OHSU Knight Cancer Institute 61

Swiss Group for Clinical Cancer Research 62

Clinical Trial Overview of Swiss Group for Clinical Cancer Research 62

National Prostate Cancer Treatment Group 63

Clinical Trial Overview of National Prostate Cancer Treatment Group 63

UNICANCER Group 64

Clinical Trial Overview of UNICANCER Group 64

Five Key Clinical Profiles 65

Appendix 161

Abbreviations 161

Definitions 161

Research Methodology 162

Secondary Research 162

About GlobalData 163

Contact Us 163

Disclaimer 163

Source 164

List of Tables

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 10

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 11

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 12

Metastatic Prostate Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 13

Metastatic Prostate Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 14

Metastatic Prostate Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 15

Metastatic Prostate Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 16

Metastatic Prostate Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 17

Proportion of Metastatic Prostate Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 18

Metastatic Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 19

Metastatic Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 20

Proportion of Metastatic Prostate Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 21

Metastatic Prostate Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 22

Metastatic Prostate Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 23

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 24

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 25

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 26

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 27

Metastatic Prostate Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 28

Metastatic Prostate Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 29

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31

Metastatic Prostate Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 32

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 36

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 42

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 44

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 45

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medivation, Inc., 2014* 46

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 47

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 48

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 49

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 50

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 51

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 52

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 53

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 56

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 57

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 58

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 59

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 60

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2014* 61

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Group for Clinical Cancer Research, 2014* 62

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Prostate Cancer Treatment Group, 2014* 63

Metastatic Prostate Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UNICANCER Group, 2014* 64

List of Figures

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 10

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 11

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 12

Metastatic Prostate Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 13

Metastatic Prostate Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 14

Metastatic Prostate Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 15

Metastatic Prostate Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 16

Metastatic Prostate Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 17

Proportion of Metastatic Prostate Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 18

Metastatic Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 19

Metastatic Prostate Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 20

Proportion of Metastatic Prostate Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 21

Metastatic Prostate Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 22

Metastatic Prostate Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 23

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 24

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 25

Metastatic Prostate Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 26

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 27

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31

Metastatic Prostate Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 32

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34

Metastatic Prostate Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 36

GlobalData Methodology 162

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 2014 MarketOptimizer.org. All rights reserved.